Sign In
Buy ADC
$72.03
-0.650 (-0.89%)
At Close: Jun 03, 2026
SAN FRANCISCO and SUZHOU, China , Dec. 8, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializ
3 Durable Dividend Stocks to Buy for a Lifetime of Passive Income
06:49am, Sunday, 08'th Dec 2024
Some dividends are more durable than others. That's due to a combination of the underlying company's financial strength and the resiliency of its business model.
My Single Biggest Regret As A REIT Investor
08:25am, Saturday, 07'th Dec 2024
I have outperformed REIT sector averages over the long run. But I could have done even better. I discuss my #1 biggest mistake I have made as a REIT investor.
9 Stocks I'm Buying As The Market Reaches A Rare Level Of Speculative Fervor
08:05am, Saturday, 07'th Dec 2024
The U.S. stock market is highly valued, driven by Big Tech and AI investments, with speculative fervor reminiscent of the late 1990s. Some REITs, like W.P. Carey, face challenges due to poor capital a
ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical Trial
07:30am, Friday, 06'th Dec 2024
Company to host corporate update webcast to share results on December 11, 2024 LAUSANNE, Switzerland , Dec. 6, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), today announced that it will host
2 REITs To Buy Before December 18th
08:25am, Thursday, 05'th Dec 2024
The Fed is about to cut interest rates again. We think that this bodes well for REITs. Here are 2 REITs that we are buying ahead of December 18th.
Realty Income: What Could Turn The Tide?
07:23am, Thursday, 05'th Dec 2024
Realty Income offers stable income but lacks recent capital appreciation. Management should focus on share buybacks to drive price appreciation. Diversified portfolio with more than 15,000 properties,
Merck's ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC
01:40pm, Wednesday, 04'th Dec 2024
This is the first breakthrough therapy designation granted to MRK's sacituzumab tirumotecan in the United States.
Gilead Collaborates With German Biotech Tubulis for Solid Tumor ADC
11:10am, Wednesday, 04'th Dec 2024
GILD and Germany-based Tubulis collaborate to discover and develop an antibody-drug conjugate against a solid tumor target.
Grab Magnificent Monthly Passive Income From 5 High-Yielding Quality Stocks
06:41am, Tuesday, 03'rd Dec 2024
Most dividend investors seek solid passive income streams from quality dividend stocks.
Realty Income Vs. Agree Realty: Is The Valuation Gap Justified
10:06pm, Monday, 02'nd Dec 2024
Agree Realty and Realty Income are often compared due to their net lease, retail-oriented structure and attractive monthly dividends. A substantial outperformance Agree Realty has delivered over Realt
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
04:30pm, Monday, 02'nd Dec 2024
LAUSANNE, Switzerland , Dec. 2, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced th
Agree Realty: 3 Reasons To Sell And Buy Realty Income
03:03pm, Monday, 02'nd Dec 2024
Agree Realty Corporation stock has had a nice run-up over the past 6 months. The stock is now in the red zone on critical metrics. We discuss these and tell what looks better.
2 Top Dividend Stocks to Buy in December
07:15am, Monday, 02'nd Dec 2024
With just a month left to the year, the S&P 500 is up 26% in 2024. Unless there's some major news over the next few weeks, the year will close out with a strong gain.
Agree Realty: Unfortunately No Longer A 'Buy' At This Price (Rating Downgrade)
08:54am, Sunday, 01'st Dec 2024
Agree Realty is one of the more impressive triple-net lease REITs out there, with an upside that's non-trivial at the right valuation. That upside is no longer there, with the company trading far high
